Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Combination Therapy in Rheumatoid Arthritis
NCT03194204Completed
- Sponsor
- Assiut University
- Start
- Oct 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline in rheumatoid arthritis (RA) (2 arms), sponsored by Assiut University. Primary endpoints: Efficacy of Doxycycline at 3 months and Safety of Doxycycline in combination with MTX. Started Oct 2019; status: completed.
02
Drugs
doxycycline
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03194204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03194204.